Guy Wendy 4

4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023

Form 4

Period: 2022-12-31

Chief Administrative Officer

Transactions

Award
Restricted Stock Units
2022-12-31+10,851→ 344,531 total
Exercise: $0.00→ Common Stock (10,851 underlying)
Award
Restricted Stock Units
2023-01-01+40,690→ 440,328 total
Exercise: $0.00→ Common Stock (40,690 underlying)
Award
Restricted Stock Units
2023-01-01+55,107→ 399,638 total
Exercise: $0.00→ Common Stock (55,107 underlying)

Footnotes (3)

[F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. These restricted stock units are fully vested on date of grant.
[F2]Each restricted stock units represents a contingent right to receive one share of the Issuers common stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.
[F3]Each restricted stock units represents a contingent right to receive one share of the tssuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.

Documents

1 file